Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
Columbia University published a new medical study on the risks of women undergoing morcellation surgery. The study found that one in 370 female patients undergoing myomectomy (uterine fibroid removal surgery) using a powered morcellator have undiagnosed sarcoma cancer in the uterus.
Power morcellators are widely used surgical tools that create small holes in the surgical area to facilitate minimally invasive laparoscopic surgeries, such as myomectomy and hysterectomies. While morcellation allows easy extraction of biological material by grinding uterine fibroids or the uterus into smaller, manageable pieces, it can also inadvertently spread cancer if it hits and grinds up an unknown sarcoma.
According to this Columbia study published in the Journal of the American Medical Association (JAMA), morcellators allegedly pose a great threat to myomectomy and hysterectomy patients. If the sarcoma is hit and spread during morcellation, the risk to a woman can be fatal. In many documented cases, morcellation on an undiagnosed sarcoma can upgrade cancer progression from stage one, known as local, to stage 4, or metastastic spread. In this stage, the cancer may spread to other areas of the body.
Based on this and other morcellation cancer studies published within the last year, many doctors and hospitals have taken a stance on the risk of power morcellators and have decided to forego morcellation in favor of safer methods to remove uterine fibroids.
In response to these decisions, the U.S. Food and Drug Administration’s public notice warning women and healthcare providers of the incidence rates of morcellation cancer and the slew of power morcellator product recalls, a number of health insurance companies have stopped coverage of power morcellation procedures.
Aside from hitting, grinding, and spreading an unknown uterine sarcoma during a hysterectomy or myomectomy, a power morcellator can also cause damage to surrounding organs during laparoscopic surgery, including the uterus, bowels, bladder, pancreas, and spleen.
Many women who have developed higher stage uterine cancer after a morcellation procedure have filed morcellation cancer lawsuits or joined morcellation cancer class action lawsuits.
In general, morcellator cancer lawsuits are filed individually by each plaintiff and are not class actions.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or class action lawsuit is best for you. Hurry — statutes of limitations may apply.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Morcellation Cancer Class Action Lawsuit Investigation
If you or a loved one were diagnosed with cancer in the uterus, pelvis or abdomen within two years of undergoing surgery for a myomectomy (removal of fibroids), hysterectomy (removal of the uterus), oophorectomy (removal of the ovaries), or salpingectomy (removal of fallopian tubes), you may have a legal claim. See if you qualify by filling out the short form below.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
Oops! We could not locate your form.
